临床试验基础设施区域市场分析：中东和北非

本报告研究了中东和北非的临床试验基础设施市场，并提供了市场概况摘要、市场影响因素和市场机会分析、市场规模趋势和预测、每个主要国家的详细分析以及竞争格局。

目录

第一章执行摘要

• 市场展望
• 研究范围
• 我们为何进行这项研究
• 市场摘要

第 2 章中东和北非临床试验产业前景

• 全球临床试验市场概览
• 中东和北非地区
• 中东和北非不断发展的临床试验产业
• 基础设施和资源：弥补新兴市场的差距
• 患者招募潜力：患者群体多样化，招募率高
• 经济高效
• 法规环境：协调与在地化
• 政府支持和投资
• 地方政策的影响：鼓励临床研究
• 合作拓展本地网路
• 新兴趋势：关注精准医疗和罕见疾病
• 肿瘤学和罕见疾病的需求不断增长
• 技术进步：临床业务数位化
• 了解中东和北非的临床试验状况

第三章 市场动态

• 市场动态
• 市场驱动因素
• 推动试验可行性的法律规范
• 增加患者人数以加强招募和多样性
• 透过技术进步提高业务效率
• 合作
• 个性化医疗试验设计
• 市场挑战
• 复杂的监管格局
• 患者招募和保留的局限性
• 基础设施和场地容量不足
• 数位技术采用有限
• 关键治疗领域的竞争
• 市场机会
• 监理改革加速核准速度
• 肿瘤学和罕见疾病的新焦点
• 透过公私合营加强研究能力
• 专注于精准医学和基因组学

第四章市场区隔分析

• 细分市场
• 市场分析：依赞助商类型
• 市场分析：按阶段
• 按服务类型进行的市场分析
• 按研究类型进行的市场分析
• 按治疗领域分類的市场分析

第五章 新兴市场

• 埃及
• 概述
• 临床试验状况分析
• 观察
• 密件抄送建议
• 沙乌地阿拉伯（KSA）
• 概述
• 临床试验状况分析
• 观察
• 密件抄送建议
• 黎巴嫩
• 概述
• 临床试验状况分析
• 观察
• 密件抄送建议
• UAE
• 概述
• 临床试验状况分析
• 观察
• 密件抄送建议
• 伊朗
• 概述
• 临床试验状况分析
• 观察
• 密件抄送建议

第六章 俄乌战争影响分析

• 概述
• 供应链中断
• 监管挑战
• 患者招募和保留
• 地缘政治风险

第七章 竞争格局

• 概述
• 竞争格局
• 国际 CRO 和製药公司
• 本地 CRO 和代理机构
• 学术研究所
• 临床试验产品和服务映射
• 中东和北非临床试验的最新趋势
• BCC的结语

第 8 章 附录

This report provides an overview of the clinical trial infrastructure markets in the Middle East and North Africa (MENA) region. It includes a detailed examination of the market dynamics and an understanding of the MENA clinical trial landscape by study status, phase, type, results and sponsor type.

Report Scope

This report analyzes the Middle East and North Africa (MENA) clinical trial markets, using 2023 as a benchmark year, and offers projections for the forecast period from 2024 to 2029, with estimates of compound annual growth rates (CAGR). The report covers many aspects of the market, including clinical advances, economic factors and business considerations, and outlines the market forces impacting the industry and its phases, study types and therapeutic areas. The report segments the clinical trial market into services, solutions and supplies, and examines the regional dynamics influencing the market.

This report excluded Turkey and Israel from its scope because their clinical trial markets are significantly more advanced than other countries in the MENA region. Including these markets would have skewed the analysis and not accurately reflected the opportunities and challenges the rest of the region faces. This approach ensures a focused examination of MENA's emerging clinical trial landscape, which may be more relevant for companies seeking to expand into less mature markets.

Report Includes

• Analysis of the Middle East and Northern Africa's (MENA) regional markets for clinical trial infrastructure
• Analyses of the market trends, with revenue data for 2023, estimates for 2024, and projected CAGRs through 2029
• Estimate of the current market size and revenue prospects, accompanied by a market share analysis by sponsor type, clinical trial phase, service type, study type, therapeutic area, and country
• An understanding of the opportunities and progressions in clinical trial studies by some select countries in emerging MENA markets
• Facts and figures pertaining to the current market dynamics, advancements in technology, regulations and prospects
• Insights of the ripple effects of the Ukraine-Russia war on clinical trial operations, including supply chain disruptions, regulatory challenges, and patient recruitment and retention
• Analysis of the industry structure, including stakeholders' market shares, clinical trial product/services mapping, and recent key developments

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Reasons for Doing this Study
• Market Summary

Chapter 2 MENA Clinical Trial Industry Outlook

• Global Clinical Trial Market Overview
• MENA Share
• Evolving MENA Clinical Trial Industry
• Infrastructure and Resources: Bridging Gaps in Emerging Markets
• Patient Recruitment Potential: Diverse Populations and High Recruitment Rates
• Cost-Effectiveness
• Regulatory Environment: Harmonization and Local Adaptations
• Government Support and Investments
• Impact of Regional Policies: Incentivizing Clinical Research
• Collaborations Expand Regional Networks
• Emerging Trends: Focus on Precision Medicine and Rare Diseases
• Growing Demand in Oncology and Rare Diseases
• Technological Advances: Digitalizing Clinical Operations
• Understanding the MENA Clinical Trial Landscape

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Regulatory Frameworks Driving Trial Feasibility
• Growing Patient Population Enhancing Recruitment and Diversity
• Technological Advances Streamlining Operations
• Collaborations
• Personalized Medicine Shaping Trial Design
• Market Challenges
• Complex Regulatory Landscape
• Limited Patient Recruitment and Retention
• Insufficient Infrastructure and Site Capacity
• Limited Adoption of Digital Technologies
• Competition for Key Therapeutic Areas
• Market Opportunities
• Regulatory Reforms Enabling Faster Approvals
• Emerging Focus on Oncology and Rare Diseases
• Public-Private Partnerships Boosting Research Capacity
• Focus on Precision Medicine and Genomics

Chapter 4 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis, by Sponsor Type
• Market Analysis, by Phase
• Market Analysis, by Service Type
• Market Analysis, by Study Type
• Market Analysis, by Therapeutic Area

Chapter 5 Emerging Markets

• Egypt
• Overview
• Clinical Trial Landscape Analysis
• Observations
• BCC Recommendations
• Kingdom of Saudi Arabia (KSA)
• Overview
• Clinical Trial Landscape Analysis
• Observations
• BCC Recommendations
• Lebanon
• Overview
• Clinical Trial Landscape Analysis
• Observations
• BCC Recommendations
• United Arab Emirates
• Overview
• Clinical Trial Landscape Analysis
• Observations
• BCC Recommendations
• Iran
• Overview
• Clinical Trial Landscape Analysis
• Observations
• BCC Recommendations

Chapter 6 Russia-Ukraine War Impact Analysis

• Overview
• Supply Chain Disruptions
• Regulatory Challenges
• Patient Recruitment and Retention
• Geopolitical Risks

Chapter 7 Competitive Landscape

• Overview
• Competitive Landscape
• International CROs and Pharmaceutical Companies
• Local CROs and Institutions
• Academic and Research Institutions
• Mapping of Clinical Trial Product Services
• Recent Developments in Clinical Trials in the MENA Region
• Concluding Remarks from BCC

Chapter 8 Appendix

• Methodology
• Research Steps
• Sources
• Abbreviations

List of Tables

• Summary Table : MENA Market for Clinical Trials, by Country, Through 2029
• Table 1 : MENA Clinical Trial Analysis, by Study Status, Through 2024
• Table 2 : Comparison of MENA Clinical Trial Regulations, Through 2024
• Table 3 : Comparison of MENA Clinical Trial Regulations, Through 2024
• Table 4 : MENA Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
• Table 5 : Regulatory Bodies for Conducting Clinical Trials in the MENA Region
• Table 6 : Recent Technological Advances in the MENA Clinical Trial Market, 2023 and 2024
• Table 7 : Recent Collaborations in the MENA Clinical Trial Market, 2024
• Table 8 : Recent Developments in Clinical Trial Infrastructure in MENA, 2023 and 2024
• Table 9 : Leading Causes of Death in MENA, by Country, 2021
• Table 10 : Recent Developments in the MENA Region, 2023 and 2024
• Table 11 : Recent Collaborations in the MENA Region, 2024
• Table 12 : Leading MENA Countries for Clinical Trials, by Sponsor Type, Through 2024
• Table 13 : MENA Market for Clinical Trials, by Sponsor Type, Through 2029
• Table 14 : Leading MENA Countries for Clinical Trials, by Phase, Through 2024
• Table 15 : MENA Market for Clinical Trials, by Phase, Through 2029
• Table 16 : MENA Market for Clinical Trials, by Service Type, Through 2029
• Table 17 : Leading MENA Countries for Clinical Trials, by Study Type, Through 2024
• Table 18 : MENA Market for Clinical Trials, by Study Type, Through 2029
• Table 19 : MENA Market for Clinical Trials, by Therapeutic Area, Through 2029
• Table 20 : Egyptian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
• Table 21 : Companies and Research Institutes for Clinical Trials in Egypt
• Table 22 : Egyptian Market for Clinical Trials, by Value, Through 2029
• Table 23 : Saudi Arabian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
• Table 24 : Companies and Research Institutes for Clinical Trials in the KSA
• Table 25 : Saudi Arabian Market for Clinical Trials, by Value, Through 2029
• Table 26 : Lebanese Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
• Table 27 : Companies and Research Institutes for Clinical Trials in Lebanon
• Table 28 : Lebanese Market for Clinical Trials, by Value, Through 2029
• Table 29 : UAE Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
• Table 30 : Companies and Research Institutes for Clinical Trials in UAE
• Table 31 : UAE Market for Clinical Trials, by Value, Through 2029
• Table 32 : Iranian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
• Table 33 : Companies and Research Institutes for Clinical Trials in Iran
• Table 34 : Iranian Market for Clinical Trials, by Value, Through 2029
• Table 35 : MENA Clinical Trials Product/Services Mapping Analysis
• Table 36 : Recent Developments in the MENA Clinical Trial Market, 2020-2024
• Table 37 : Information Sources in this Report
• Table 38 : Abbreviations Used in this Report

List of Figures

• Summary Figure : MENA Market for Clinical Trials, by Country, 2023-2029
• Figure 1 : Global Market for Clinical Trials, by Value, 2023-2029
• Figure 2 : Share of the Global Clinical Trials Market Value, by Region, 2023
• Figure 3 : Key Considerations for MENA Clinical Trials
• Figure 4 : Market Dynamics of Clinical Trial Infrastructure in the MENA Region
• Figure 5 : Share of Deaths, by Broad Cause, by Country, 2021
• Figure 6 : Share of MENA Market for Clinical Trials, by Sponsor Type, 2023
• Figure 7 : Share of MENA Market for Clinical Trials, by Phase, 2023
• Figure 8 : Share of MENA Market for Clinical Trials, by Service Type, 2023
• Figure 9 : Share of MENA Market for Clinical Trials, by Study Type, 2023
• Figure 10 : Share of MENA Market for Clinical Trials, by Therapeutic Area, 2023
• Figure 11 : Egyptian Market for Clinical Trials, by Value, 2023-2029
• Figure 12 : BCC Recommendations for the Egyptian Market for Clinical Trials
• Figure 13 : Saudi Arabian Market for Clinical Trials, by Value, 2023-2029
• Figure 14 : BCC Recommendations for Saudi Arabian Clinical Trials
• Figure 15 : Lebanese Market for Clinical Trials, by Value, 2023-2029
• Figure 16 : BCC Recommendations for Lebanese Clinical Trials
• Figure 17 : UAE Market for Clinical Trials, by Value, 2023-2029
• Figure 18 : BCC Recommendations for the UAE Clinical Trials
• Figure 19 : Iranian Market for Clinical Trials, by Value, 2023-2029
• Figure 20 : BCC Recommendations for the Iranian Clinical Trials
• Figure 21 : Share of MENA Market for Clinical Trials, by Stakeholder, 2024
• Figure 22 : Recommendations for Companies Looking to Enter the MENA Clinical Trial Market
• Figure 23 : Methodology Used in the MENA Clinical Trial Market